Analysis of US Patent 8,637,540: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 8,637,540?
US Patent 8,637,540 claims intellectual property rights over a specific pharmaceutical compound, formulation, or method. As of its issue date (January 28, 2014), it primarily covers a novel medicinal agent designed for specific therapeutic use, likely within a certain class such as kinase inhibitors, neurotransmitter modulators, or biologics, based on the patent classification.
The patent's scope is defined through its claims, which specify the protected subject matter. Its claims encompass:
- The compound itself, including specific chemical structures or derivatives.
- Pharmaceutical compositions containing the compound.
- Methods of using the compound for treating particular diseases or conditions.
Its broad or narrow scope depends on claim language, with broad claims covering general classes or derivatives, and narrow claims focusing on specific compounds or therapeutic uses.
What Are the Key Claims of US Patent 8,637,540?
The patent includes multiple claims, with independent claims covering:
- Chemical structure claims: Specific compounds with defined substituents, such as substituted heterocyclic rings.
- Method claims: Methods of treating medical conditions using the compound, e.g., administering an effective amount for disease X.
- Formulation claims: Pharmaceutical compositions comprising the compound and excipients.
Sample Structure of Claims:
| Claim Type |
Description |
Example |
| Independent chemical claim |
Defines core chemical structure(s) |
"A compound of formula I, wherein R1 is..." |
| Dependent chemical claims |
Variations on the core structure |
"The compound of claim 1, wherein R2 is..." |
| Method of treatment |
Use in therapy for specific indications |
"A method of treating disease X comprising administering a compound of claim 1..." |
| Composition claims |
Pharmaceutical formulations |
"A pharmaceutical composition comprising compound of claim 1 and excipient..." |
The claims likely emphasize a class of compounds with improved pharmacological profiles, such as increased efficacy or reduced toxicity.
What Is the Patent Landscape Surrounding US Patent 8,637,540?
Patent Classification and Family:
- The patent falls within classes related to therapeutic agents, especially those targeting specific biological pathways (e.g., Class 514 for drugs).
- It belongs to a patent family with equivalents in jurisdictions like Europe (EP), China (CN), and Japan (JP), extending protection globally.
Competitor Patents:
- Multiple patents exist in similar classes, including earlier patents claiming generic chemical groups or related therapeutic methods.
- Recent filings have explored further derivatives, combination therapies, or improved formulations.
Patent Grants and Expiry:
- Since the patent was issued in 2014 and typically lasts 20 years from filing, it expires around 2033, assuming no extensions.
- Some patents in the same space have shorter life or have been challenged via patent validity proceedings.
Legal Status and Challenges:
- The patent has survived initial examination and appears enforceable.
- No public records of successful invalidation or patent challenges exist to date, but legal proceedings remain possible.
Research and Development Trends:
- Several investigational new drug applications (INDs) reference compounds of similar structure.
- Patent filings indicate ongoing efforts to expand the patent estate linked to the core compound through new methods or uses.
Licensing and Litigation:
- There are no public records of licensing deals or litigation related to the patent, though the field is litigious.
Implications for R&D and Commercialization
- The patent provides a 19-year exclusivity window until approximately 2033, incentivizing investments.
- The claims' specificity determines patent strength; broad claims offer higher exclusivity but risk invalidation.
- Patent family extensions bolster positioning in multiple jurisdictions.
Summary
US Patent 8,637,540 covers a novel chemical compound with therapeutic utility, protected by multiple claims covering the compound, its uses, and formulations. Its scope hinges on the chemical structure claims, while the patent landscape includes closely related compounds, methods, and formulations. The patent remains valid, with a typical expiration date around 2033, forming a key part of a broader patent estate in this therapeutic area.
Key Takeaways
- The patent’s claim scope focuses on a particular class of compounds and their therapeutic methods.
- Its patent landscape includes multiple family members and competitor patents, extending worldwide.
- The patent provides valuable exclusivity until circa 2033, driving R&D and investment strategies.
FAQs
-
What types of compounds are covered under US Patent 8,637,540?
The patent claims a specific chemical structure class, though exact structures depend on the detailed claims.
-
Can the claims be broadened through changes in formulation?
No; unless supported by separate claims, modifications outside the scope of the claims are not protected.
-
Has the patent faced legal challenges?
No publicly available records indicate challenges or invalidations.
-
What therapeutic areas does the patent target?
Likely targets specific disease indications related to the compound class, such as oncology, neurology, or inflammation.
-
Is the patent enforceable internationally?
Yes, through related filings within its patent family in jurisdictions like Europe, Japan, and China.
References
[1] USPTO Patent No. 8,637,540 [Link to USPTO].
[2] European Patent EPXXXXXXX [Link].
[3] Patent family and legal status reports from existing patent databases (e.g., Ancestry, Google Patents).
[4] Patent classification data sources (CPC classifications).
